Allegheny Financial Group LTD - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allegheny Financial Group LTD ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$16,000
-38.5%
13,950
-3.3%
0.01%
-33.3%
Q2 2022$26,000
-10.3%
14,4240.0%0.01%0.0%
Q1 2022$29,000
-29.3%
14,424
-4.5%
0.01%
-25.0%
Q4 2021$41,000
-42.3%
15,099
-4.7%
0.02%
-51.5%
Q3 2021$71,000
-22.8%
15,8490.0%0.03%
-21.4%
Q2 2021$92,000
-17.1%
15,8490.0%0.04%
-48.1%
Q1 2021$111,000
+46.1%
15,8490.0%0.08%
+97.6%
Q4 2020$76,00015,8490.04%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders